Related Experiment Video

Updated: Mar 30, 2026

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

9.9K

Overexpression of miR-210 is Associated with Poor Prognosis of Acute Myeloid Leukemia

Xiaoqiong Tang1, Liping Chen1, Xinyu Yan1

  • 1Department of Hematology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China (mainland).

Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|November 10, 2015
PubMed
Abstract

Insights

High miR-210 levels in acute myeloid leukemia (AML) patients indicate a poor prognosis. This microRNA may serve as a valuable biomarker for predicting clinical outcomes in AML.

Area of Science:

  • Hematology
  • Molecular Biology
  • Oncology

Background:

  • MicroRNAs are key regulators in acute myeloid leukemia (AML) initiation and progression.
  • The role of miR-210 in AML development is known, but its prognostic significance remains unclear.
  • This study investigates the relationship between miR-210 expression and AML prognosis.

Purpose of the Study:

  • To determine the expression level of miR-210 in AML patients.
  • To evaluate the correlation between miR-210 expression and clinical parameters in AML.
  • To assess the prognostic value of miR-210 in AML.

Main Methods:

  • Real-time quantitative PCR was used to measure miR-210 expression in bone marrow and serum from AML patients and healthy controls.
  • Correlations between miR-210 levels and clinical parameters (overall survival, relapse-free survival) were analyzed.
  • Multivariate analysis was performed to identify independent prognostic markers.

Main Results:

  • miR-210 expression was significantly elevated in AML patients' bone marrow and serum compared to controls (p<0.001).
  • miR-210 levels correlated with FAB classification and cytogenetics in AML.
  • Higher miR-210 expression was linked to poorer relapse-free survival (p=0.015) and overall survival (p=0.008).
  • Serum miR-210 decreased significantly upon achieving complete remission (p=0.02).
  • miR-210 was identified as an independent prognostic marker in multivariate analysis.

Conclusions:

  • Upregulated miR-210 is associated with poor prognosis in acute myeloid leukemia.
  • miR-210 may serve as a potential biomarker for predicting clinical outcomes in AML patients.

More Related Videos

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

9.0K
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

8.1K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.6K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
6.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K